Skip to main content

Advertisement

Basic, translational and clinical research

Cancer NanotechnologyCancer is a group of diseases driven by inherently nanostructural problems. As such, there are obvious benefits to treatments employing nanoscale structures and processes. Cancer Nanotechnology aims to provide a forum so that the most promising emerging themes should be pre-eminent in the minds of researchers working in one—or, indeed, both—of the disciplines of cancer research or nanotechnology.
Read our Editorial to learn more

Special article collections

Cancer Nanotechnology publishes special article collections on specific topics. Be sure to take a look at the list of collections we have so far by clicking the link above. 

We welcome further submissions to these collections. 

Alternatively, maybe you have a suggestion for a special collection of your own that you would like to edit. We'd love to hear from you if so!

New collection — Multiscale Modelling for Cancer Radiotherapies: from X-rays to ions

Our new collection, edited by Andrey Solov'yov and Eugene Surdutovich, has started publishing! The collection provides a platform for scholars and practitioners in disciplines such as physics, chemistry, biology, and medical science, to share and exchange their research, knowledge, and insights related to the scientific base of assessment of cell inactivation in the course of radiation therapy of different modalities from x-rays to ions.

Articles

  1. Content type: Review

    Authors: Kaspar Haume, Soraia Rosa, Sophie Grellet, Małgorzata A. Śmiałek, Karl T. Butterworth, Andrey V. Solov’yov, Kevin M. Prise, Jon Golding and Nigel J. Mason

Most accessed articles RSS

View all articles

Stay up to date

Do you want to stay up to date on the latest from Cancer Nanotechnology? Sign up for article alerts and news from this journal in order to receive updates for recently published articles, as well as news about Cancer Nanotechnology and BMC. 

Cancer Nanotechnology now included in SCIE

Cancer Nanotechnology is now as a part of the Science Citation Index Expanded (SCIE), which means it is fully searchable in Web of Science, published by Clarivate Analytics. 

Starting 2020, Cancer Nanotechnology will be included in the annual Journal Citation Reports, at which point it will receive the associated journal metrics, such as Immediacy Index, Eigenfactor Score and Journal Impact Factor.

Latest Tweets

Advertisement

2018 Journal Metrics

Advertisement